fda update on tirzepatide approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Diabetes Drug - Tirzepatide Gets

We chose the async review, but a follow-up message told us a video call was required, so we scheduled a 15-minute appointment for the next available slot two days out

Gastroparesis/stomach paralysis Doctors have also reported patients experiencing stomach paralysis, also called gastroparesis or delayed gastric emptying

This is the latest disappointment in what has been a bumpy ride in Pfizer's attempt to enter the hot obesity market and compete with market leaders Eli Lilly (LLY) and Novo Nordisk (NVO)

Youve heard of Ozempic butt, Ozempic fingers, Ozempic mouth and Ozempic teeth now, theres a new term to add to the GLP-1 lexicon: Ozempic breath. Bad breath is a common side effect of GLP-1 diabetes and weight loss drugs like Ozempic because they slow digestion, causing food to linger and ferment in the stomach